1. A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab
- Author
-
Nawras Alshoubaki, Agnes K. Liman, Mohan Ramkumar, Andrew D. Liman, Roy Frye, Kevin Quann, and Chaoyuan Kuang
- Subjects
Oncology ,medicine.medical_specialty ,lcsh:Medicine ,Case Report ,Case Reports ,monoclonal gammopathy of renal significance ,030204 cardiovascular system & hematology ,urologic and male genital diseases ,03 medical and health sciences ,0302 clinical medicine ,Glomerulopathy ,Internal medicine ,Rare case ,Medicine ,lcsh:R5-920 ,business.industry ,nephrotic syndrome ,lcsh:R ,General Medicine ,medicine.disease ,Monoclonal gammopathy ,Waldenstrom's macroglobulinemia ,030220 oncology & carcinogenesis ,Monoclonal ,Rituximab ,medicine.symptom ,immunotactoid glomerulopathy ,business ,lcsh:Medicine (General) ,Nephrotic syndrome ,Bortezomib/dexamethasone ,medicine.drug - Abstract
Patients with monoclonal gammopathy of renal significance should be treated with clone‐directed therapy against sources of monoclonal proteins in order to prevent progression to more advanced monoclonal gammopathies and renal failure.
- Published
- 2020